Cargando…
KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype
Netherton syndrome (NS) is a severe skin disease caused by the loss of protease inhibitor LEKTI, which leads to the dysregulation of epidermal proteases and severe skin-barrier defects. KLK5 was proposed as a major protease in NS pathology, however its inactivation is not sufficient to rescue the le...
Autores principales: | Kasparek, Petr, Ileninova, Zuzana, Zbodakova, Olga, Kanchev, Ivan, Benada, Oldrich, Chalupsky, Karel, Brattsand, Maria, Beck, Inken M., Sedlacek, Radislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283769/ https://www.ncbi.nlm.nih.gov/pubmed/28095415 http://dx.doi.org/10.1371/journal.pgen.1006566 |
Ejemplares similares
-
KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome
por: Furio, Laetitia, et al.
Publicado: (2015) -
KLK4T2 Is a Hormonally Regulated Transcript from the KLK4 Locus
por: Lundwall, Åke, et al.
Publicado: (2021) -
Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
por: Buryova, Halka, et al.
Publicado: (2013) -
ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis
por: Zbodakova, Olga, et al.
Publicado: (2021) -
A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33
por: Parikh, Hemang, et al.
Publicado: (2009)